Horvat, T. Z., Adel, N. G., Dang, T., Momtaz, P., Postow, M. A., Callahan, M. K., . . . Chapman, P. B. (2015). Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center. Journal of clinical oncology, 33(28), 3193. https://doi.org/10.1200/JCO.2015.60.8448
Chicago-Zitierstil (17. Ausg.)Horvat, Troy Z., et al. "Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center." Journal of Clinical Oncology 33, no. 28 (2015): 3193. https://doi.org/10.1200/JCO.2015.60.8448.
MLA-Zitierstil (9. Ausg.)Horvat, Troy Z., et al. "Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center." Journal of Clinical Oncology, vol. 33, no. 28, 2015, p. 3193, https://doi.org/10.1200/JCO.2015.60.8448.